A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1997
12/11/1997	WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/11/1997	WO1997046250A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
12/11/1997	WO1997046249A1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies
12/11/1997	WO1997046248A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
12/11/1997	WO1997046207A2 Aromatic heterocyclic derivatives as enzyme inhibitors
12/11/1997	WO1997046206A2 Human thyrotropin receptor compositions and use thereof
12/11/1997	WO1997038082A3 Hypertonia gene
12/11/1997	DE19622866A1 Verwendung von Opiat-Antagonisten und -Agonisten enthaltende Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen Use of opiate antagonists and agonists containing preparations for the prophylaxis and therapeutic treatment of migraine and migraine related disorders
12/11/1997	CA2261637A1 A human radioresistance/cell cycle progression gene
12/11/1997	CA2258720A1 Human thyrotropin receptor compositions and use thereof
12/11/1997	CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
12/11/1997	CA2257531A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides
12/11/1997	CA2257474A1 Ob protein binding protein
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2257243A1 Polynucleotides from human adult pbmc encoding secreted proteins
12/11/1997	CA2257240A1 Fragments of leptin (ob protein)
12/11/1997	CA2257174A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
12/11/1997	CA2257140A1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies
12/11/1997	CA2257119A1 Exendin analogues, processes for their production and pharmaceutical preparations containing them
12/11/1997	CA2257108A1 Novel peptides and production and use thereof
12/11/1997	CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	CA2256522A1 Polynucleotides encoding secreted proteins
12/11/1997	CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells
12/11/1997	CA2256464A1 Tumor necrosis factor-related polypeptide
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/11/1997	CA2254862A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses
12/11/1997	CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression
12/11/1997	CA2252417A1 Peptide derivatives
12/11/1997	CA2251536A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
12/11/1997	CA2228618A1 Novel feline cytokine protein
12/11/1997	CA2228301A1 Materials and methods for detection of breast cancer
12/10/1997	EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification
12/10/1997	EP0811691A1 Antibody againts alpha-chain of human interleukin 5 receptor
12/10/1997	EP0811688A2 Staphylococcus aureus RNase P
12/10/1997	EP0811687A2 Polypeptides having l-asparaginase activity
12/10/1997	EP0811686A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811685A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same
12/10/1997	EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease
12/10/1997	EP0811384A1 Muscle protein decomposition inhibitor containing il-6 receptor antibody
12/10/1997	EP0811383A1 Remedies for arthrosis deformans and inflammatory joint diseases
12/10/1997	EP0811382A1 Mammography method
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library
12/10/1997	EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
12/10/1997	EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997	EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
12/10/1997	EP0811073A2 Methods and compositions for administering gene therapy vectors
12/10/1997	EP0811072A1 Transgenic animals as model of psoriasis
12/10/1997	EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
12/10/1997	EP0811068A1 HUMAN DNase I VARIANTS
12/10/1997	EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/10/1997	EP0811065A1 Antagonists of interleukin-15
12/10/1997	EP0811064A2 Mpl ligand analogs
12/10/1997	EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies
12/10/1997	EP0811061A1 Multiple-tumor aberrant growth genes
12/10/1997	EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
12/10/1997	EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0810884A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
12/10/1997	EP0810882A1 Methods and compositions for regulation of cd28 expression
12/10/1997	EP0810881A1 Delivery of therapeutic agents by gene therapy
12/10/1997	EP0810875A1 Multifunctional enzyme
12/10/1997	EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
12/10/1997	EP0810873A1 Antiviral combinations of bch-189 and ritonavir
12/10/1997	EP0810872A1 Anti-obesity proteins
12/10/1997	EP0810871A1 Anti-obesity proteins
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/10/1997	EP0659193B1 Platelet aggregation inhibitors
12/10/1997	EP0610246B1 Novel thrombin-inhibiting protein from ticks
12/10/1997	EP0567503B1 Pasteurella haemolytica glycoprotease gene
12/10/1997	EP0504335B1 A fibronectin binding peptide
12/10/1997	EP0477201B1 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic application thereof
12/10/1997	EP0440744B1 Products and methods for controlling the suppression of the neoplastic phenotype
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167491A Synthetic IgE membrane anchor peptide immunogens for the treatment of allergy
12/10/1997	CN1167441A New Therapeutical utilization of superoxide dismutases
12/10/1997	CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer
12/10/1997	CN1167150A Method for production of recombining human grunulocyte colony stimulation factor
12/10/1997	CN1167115A Anti-Fas recombinant antibodies and DNA therefor
12/10/1997	CN1167114A Calcitonin-like material of salmon and eel without dithio-bond and preparation method
12/09/1997	US5696270 Intermediate for making retroviral protease inhibiting compounds
12/09/1997	US5696253 Polynucleoside chain with 3'→5' guanidyl linkages
12/09/1997	US5696250 Having one or more changed glycosylation sites; cloned cytokine
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696236 Method for the removal of viruses from protein solutions
12/09/1997	US5696234 Muteins of mammalian cytokine interleukin-13
12/09/1997	US5696231 N-substituted glycine derivatives as enzyme inhibitors
12/09/1997	US5696230 Acyclic oligopeptide having constrained backbone conformation and spasmogenic, platelet aggregatory, neutrophil polarization and/or neutrophil enzyme release activity
12/09/1997	US5696229 Polypeptide with laminin cell adhesion and morphogenesis activity
12/09/1997	US5696159 Lactone compounds for treating patients with precancerous lesions
12/09/1997	US5696147 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
12/09/1997	US5696135 Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
12/09/1997	US5696134 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/09/1997	US5696128 Adjustment prolactin profile
12/09/1997	US5696116 Pharmaceutical composition which contains a renin angiotensin system inhibitor and an endothelin antagonist
12/09/1997	US5696093 Administering polypeptide having cardiac vagal inhibiting action without pressor action
12/09/1997	US5696092 Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers

1 ... 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 ... 3163